1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BA5EEAC5612769FB85257FF800551678
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/BA5EEAC5612769FB85257FF800551678!OpenDocument
18
19OpenDocument
2018.208.126.232
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Brand+Management+and+Product+Leadership

Document Excerpt: Best Practices in Global Branding for New Products: Alignment with Affiliates, Tradename Development and Participant Narratives

DB Image

ID: MD-527


Features:

22 Info Graphics

15 Data Graphics

125+ Metrics

14 Narratives


Pages/Slides: 4


Published: Pre-2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5426 "Best Practices in Global Branding for New Products: Alignment with Affiliates, Tradename Development, and Participant Narratives."

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Automobile; Consulting; Health Care; Biotech; Clinical Research; Laboratories; Computer Hardware; Research


Companies Profiled:
Alkermes; Allergopharma; Asklepion Pharmaceuticals; LLC; ASMC; Axovant Sciences; Biolink Marketing LLC; Boehringer Ingelheim; Cempra; Everex Pharmaceuticals; EMD Serono; Grifols; HUYA Bioscience International; Inovio Pharmaceuticals; Merck; Pfizer; Sanofi; Teva Pharmaceutical Industries Ltd; Toshiba; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.